Sabine Vogler - Gesundheit Österreich GmbH (Austrian Public Health Institute, GÖG)
Dr Sabine Vogler is Head of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies affiliated to the Department at the Austrian Public Health Institute. She is senior researcher and Head of the Pharmacoeconomics Department. Sabine Vogler has expertise and in-depth knowledge about European countries with regard to pharmaceutical pricing/prices, reimbursement and distribution, as well as cost-containment reforms, access and affordability issues. She is/was the principal investigator of large projects including the PPRI (Pharmaceutical Pricing and Reimbursement Information) project, the PHIS (Pharmaceutical Health Information System) project and a Study on enhanced cross-country coordination in the area of pharmaceutical product pricing, and she manages the on-going PPRI network. She published several articles, studies and reports. Before joining the Austrian Health Institute in 1995, Dr. Vogler worked at the Department of Social Policies at the Vienna University of Business Administration and Economics where she obtained her PhD for her thesis on care for elderly people.
Hanne Bak Pedersen - WHO, Regional Office for Europe
Hanne Bak Pedersen is programme manager for health technologies and pharmaceuticals at the Division of Health Systems and Public health at the WHO Regional Office for Europe. Her topics of Interest are rational pharmacotherapy, systems for valuation of health technology, HTA, medicines for children, improving access to essential medicines and health technologies and user perspectives. Before, Hanne Bak Pedersen worked in the UNICEF Supply Division.
Nina Zimmermann - Gesundheit Österreich GmbH (Austrian Public Health Institute, GÖG)
Nina Zimmermann works for the of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies affiliated to the Pharmacoeconomics Department at the Austrian Public Health Institute. She has been working for the secretariat of the PPRI network at the Austrian Public Health Institute since 2009. Ms. Zimmermann was a key researcher in - to- major EU projects on pharma-economic issues (PPRI, PHIS) and other relevant projects at (inter-)national level in the pharmaceutical field (e.g. Pharma Policy Mix 2013). She organized the last PPRI Conference in 2011 in Vienna. She has experience in international, national and regional research of pharmaceutical systems and pharmaceutical policy analysis in the EU Member States. Nina Zimmermann has a master’s degree in Health Management from the University of Applied Science Krems, Austria. Furthermore she completed a master course on ‘European studies - Management of EU projects’ at the University of Applied Science Eisenstadt, Austria. She has also gained previously working experience in the fields of injury prevention and addiction prevention as well as international cooperation and research projects.
Peter Schneider - Gesundheit Österreich GmbH (Austrian Public Health Institute, GÖG)
Peter Schneider holds a degree in Economics and a Master degree in Economics of International Trade and European Integration. He is involved in the PPI (Pharma Price Information) team, the European medicine price database EURIPID project, WHO Collaborating Centre and ongoing projects in the Austrian health care reform process. He is also member of the Austrian Health Economics Association (ATHEA). His research areas are pricing and reimbursement of pharmaceuticals, analysis and comparison of health and pharmaceutical systems, health economics and pharmacoeconomics.
Andrew Rintoul - WHO Headquarter
Andrew Rintoul is a Health Economist who joined World Health Organization in Geneva in January this year. He works in the Department of Essential Medicines and Health Products. Before joining the World Health Organisation he worked for the Australian Government Department of Health on the Pharmaceutical Benefits Scheme for 12 years. From 2011 until end 2016, he was Director of Pharmaceutical Pricing, where he was responsible for pharmaceutical pricing and pricing negotiations for the Australian Government.
Guillaume Dedet - WHO, Regional Office for Europe
Guillaume Dedet is a public health physician trained in Paris with a significant academic background in statistics (Université Paris Sud) and health economics (London School of Economics). His main areas of interest cover health technology assessment and pharmaceutical pricing policies. He is currently a technical officer in the Health Technologies and Pharmaceuticals unit at the WHO regional office for Europe. Prior joining WHO, Guillaume Dedet served as the medical advisor in the pharmaceuticals pricing and reimbursement department at the French Ministry of Health.
Jane Robertson - WHO, Regional Office for Europe
Jane Robertson is a pharmacist and Technical Officer in the Health Technologies and Pharmaceuticals Programme at the WHO Regional Office for Europe. Before joining WHO, she was an academic at the University of Newcastle, Australia with expertise in pharmacoepidemiology and pharmacoeconomics. She coordinates and provides technical support and advice to Member States on matters related to antimicrobial medicines consumption, rational use of medicines, selection of essential medicines and health technology assessment.
Tifenn Humbert - WHO, Regional Office for Europe
Tifenn Humbert is a Public Health Pharmacist with more than fifteen years of experience in procurement supply and chain management (PSM), health system strengthening, health logistics and procurement of medicines. She joined WHO in 2012 as Procurement Officer at the WHO global Services Center in Kuala Lumpur (Malaysia) where she was responsible of the global procurement of medical items for WHO emergency responses, as the vaccines emergency stockpiles for cholera and meningitis, the emergency health kits etc. Since April 2016, she has been working in the WHO Regional Office in Copenhagen, in the health Technologies and Pharmaceuticals, Division of Health Systems and Public Health. Her work focuses on provide technical support to the countries in the region in the area of Strategic Procurement for medicines. She was involved in the publication of the WHO report Challenges and opportunities in improving access to medicines through efficient public procurement in the WHO European Region. She has a Master in Public Health in Developing countries from the London School of Hygiene and Tropical medicines (LSHTM). Before working with WHO, she was working with UNICEF (Regional Office for West and Central Africa in Dakar, Senegal as HIV/AIDS Program Officer to assess the availability of ARVs medicines in the region; with UNICEF Supply Division in Copenhagen, Denmark to procure ARVs medicines and vaccines. She also worked in emergency projects with medical NGOs (Medecins Sans Frontieres) in Kosovo and in Africa in the area of health logistics, capacity building and procurement.
Esteban Burrone - Medicines Patent Pool
Esteban Burrone is the Head of Policy for the Medicines Patent Pool. Esteban has been with the MPP since its establishment in 2010 and oversees the MPP’s partnerships with a wide range of external stakeholders including governments, intergovernmental organisations, civil society and community-based organisations. He is part of the senior management team of the organisation and has overall responsibility for the MPP’s Patent Status Database and for the annual HIV product prioritisation. Esteban has more than 15 years of experience working in the field of innovation, intellectual property rights and access to medicines with a focus on developing countries. Esteban holds a Master of Science in Development Studies from the London School of Economics and a Master in Business Administration (MBA) from the International University in Geneva.